ArticleJournal of clinical laboratory analysis2022

Neoadjuvant chemotherapy endows CD9 with prognostic value that differs between tumor and stromal areas in patients with pancreatic cancer.

Xuan Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.